Pre-Conference Workshops

Scientific Theory to Drug Development Workshop Foundational Science to Inform Next Generation Drug Targets & Research Progress

10:30 am Investigating the Inflammasome: Supporting the Involvement of the Inflammasome in Drug Development for Kidney Disease

  • Robert Keane Professor, Departments Of Physiology, Biophysics & Neurological Surgery, University of Miami

11:00 am Inflammation at the Heart of Chronic Kidney Disease Patients: Anti-Interleukin Therapy?

  • Matt Devalaraja Chief Scientific Officer, Head of R&D, Corvidia Therapeutics

11:30 am Renal Lipids as a Potential Therapeutic Target for Kidney Disease

  • Nick LaBella Chief Scientific Officer, ZyVersa Therapeutics

12:00 pm Lunch & Networking

1:00 pm Role of Vascular Smooth Muscle Cell (SMC) TRPV4 Channel in IschemiaReperfusion-Induced Renal Insufficiency in Neonatal Pigs

  • Hitesh Soni Renal Fibrosis Gene Therapy Lead , Renascent Biosciences

1:30 pm Investigating the Fezagepras-Family of Antifibrotic Compounds in Kidney Disease; from Bench to Clinic

2:00 pm Workshop Ends